[Drug interactions in the treatment of arterial hypertension: an emerging problem].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D004071:Digitalis Glycosides / Q000494:pharmacology; D004347:Drug Interactions; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000929:Antidepressive Agents, Tricyclic; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002800:Cholinesterase Inhibitors; D004071:Digitalis Glycosides; D006635:Histamine H2 Antagonists; D007004:Hypoglycemic Agents; D003000:Clonidine
Le interazioni farmacologiche nel trattamento dell'ipertensione arteriosa: un problema emergente.